Study to Reduce Intravenous Exposures
Investigators: Steffanie Strathdee, Ph.D., Sebastian Booner, Ph.D., Elizabeth Golub, Ph.D., Mary Latka, M.P.H., Ph.D., Farzana Kapadia, Ph.D., Holly Hagan, M.P.H., Ph.D., Jennifer Campbell, & Richard Garfein, Ph.D., M.P.H

STRIVE is a group-level, clinic-based, behavioral intervention that aims to reduce risky distributive injection practices (e.g., syringe lending and unsafe drug preparation) among young injection drug users who are HCV positive. During six 2-hour sessions, two trained health advisors promote group cohesion and support peer education within the STRIVE group. The health advisors encourage behavior change by teaching peer-education tactics and risk reduction skills. The STRIVE program increases participants. HCV knowledge and risk awareness, problem-solving and risk-reduction skills, and supports sustained behavior change. View more detailed information on this program.

Materials in this program package are licensed for use in one implementation site. All materials are copyrighted and may not be copied or distributed. If you would like to order additional materials or program packages, please contact Customer Support. Email: socio@socio.com Tel: 650-949-3282.

Digitized Version is Coming Soon.


STRIVE Program Package
   
STRIVE Program Package
Price: $250.00
Add to cart

STRIVE User's Guide
   
STRIVE User's Guide
Price: $18.00
Add to cart